We have previously identified ErbB2 as an in vitro carrier of both α2,3- (sialyl Lewis a (SLea)) and α2,6NeuAc glycan epitopes in ERBB2-amplified GC cells [8]. Here, ERBB2 is linked to gastric cancer.